Tang Capital Management LLC Vincerx Pharma, Inc. Transaction History

Tang Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.64 - $1.32 $594,478 - $1.23 Million	-928,872 Reduced 90.13%	101,762 $103,000
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $14.3 Million	530,634 Added 106.13%	1,030,634 $13.4 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $11.3 Million - $15.5 Million	500,000 New	500,000 $9.65 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.03M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.